Read Our Impact Stories

See how CLEW’s early identification of patient deterioration results
in exceptional patient care here.

PREDICTING THE RISK OF PATIENT DETERIORATION

CLEW offers the first FDA-cleared, AI-based clinical predictive models for high-acuity care. With an optimal balance of precision and sensitivity, its peer-reviewed predictive insights have been documented to be at least five times more accurate than other systems.

Learn more about our FDA Clearance.

Read Now

CREATING OPPORTUNITIES FOR EARLY INTERVENTION

With truly accurate predictions of patient deterioration, up to eight hours before patient monitoring systems would suspect, CLEW gives hospitals and health systems the opportunity for early intervention. This leads to decreases in mortality and reductions in complications and readmissions.

IMPROVING OPERATIONAL AND CLINICAL OUTCOMES 

Early identification of patient deterioration allows caregivers time to intervene proactively, which leads to decreases in unforeseen bottlenecks, reducing length of stay, improving capacity management and access to care. 

Proven Superior Accuracy & Efficiency

READ THE CHEST JOURNAL STUDY

5x more
accurate

A CHEST Journal study found CLEW notifications to be 5 times more accurate than the leading telemedicine system. Learn more about the peer-reviewed study on the efficiency of our prediction models here.

View more News
AvaSure Teams Up with CLEW Medical to Boost High-Acuity Care with AI-Driven Virtual Surveillance
AvaSure, a market leader in acute virtual care, and CLEW Medical, an AI-enabled clinical surveillance and predictive analytics company, announced their partnership to drive early detection of critical care patient deterioration. from AvaSure Teams Up with CLEW Medical to Boost High-Acuity Care with AI-Driven Virtual Surveillance

Select
Healthcare IT News: AI tackles patient deterioration, obesity and stroke
CLEW Medical is unveiling new FDA-cleared machine learning algorithms that not only reduce patient condition alerts, but have also been shown to increase accuracy in detecting clinical deterioration. from Healthcare IT News: AI tackles patient deterioration, obesity and stroke

Read More
CLEW MEDICAL SECURES FDA CLEARANCE FOR SECOND-GENERATION AI MODELS
CLEW announced that its second-generation, AI/machine-learning models for predicting patient deterioration have received 510(k) clearance from the Food & Drug Administration (FDA). from CLEW MEDICAL SECURES FDA CLEARANCE FOR SECOND-GENERATION AI MODELS

Learn More
CLEW EXPANDS ITS INTELLIGENT CLINICAL SURVEILLANCE PLATFORM TO ALL INPATIENT SETTINGS
The FDA-cleared system is proven to accurately predict patient deterioration, reduce caregiver burden and create opportunities for early intervention. from CLEW EXPANDS ITS INTELLIGENT CLINICAL SURVEILLANCE PLATFORM TO ALL INPATIENT SETTINGS

Select

Widespread Challenges in Healthcare

RISING PATIENT ACUITY

Greater percentage of high-acuity patients require extensive care resources

CLINICIAN SHORTAGE

Staff arrives increasingly less experienced on systems, workflows and clinical protocols

CAPACITY CONSTRAINTS

Unforeseen patient deterioration leads to increases in length of stay

Empowering Health Systems & Providers

Learn about improving patient outcomes for your organization.

Explore

ALLOWS FOR EARLY INTERVENTION

Provides caregivers insights based on real-time patient physiology

DRIVES PROACTIVE CLINICAL EXCELLENCE

Enables decision support for complex clinical scenarios

ENABLES RESOURCE OPTIMIZATION

Leaders have advanced clinical insights when making staffing assignments

REDUCES NURSING BURNOUT

Fewer alerts and false alarms results in fewer disruptions for caregivers

IMPROVES ACCESS TO CARE

Early intervention leads to reduced length of stay and increased capacity

Receive the latest updates from CLEW

"*" indicates required fields

Name*

Selected Partners

Selected Customers